QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 1 filers reported holding QIAGEN NV in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,512,000 | -27.0% | 161,029 | -28.5% | 0.01% | -31.6% |
| Q3 2016 | $6,182,000 | +6.2% | 225,293 | -15.6% | 0.02% | +5.6% |
| Q2 2016 | $5,819,000 | -10.7% | 266,790 | -8.5% | 0.02% | -14.3% |
| Q1 2016 | $6,516,000 | -30.2% | 291,669 | -13.7% | 0.02% | -22.2% |
| Q4 2015 | $9,341,000 | -2.9% | 337,826 | -9.4% | 0.03% | -10.0% |
| Q3 2015 | $9,624,000 | -23.5% | 373,031 | -26.5% | 0.03% | -3.2% |
| Q2 2015 | $12,586,000 | +12.4% | 507,720 | +14.2% | 0.03% | +14.8% |
| Q1 2015 | $11,202,000 | +8.6% | 444,554 | +1.1% | 0.03% | +3.8% |
| Q4 2014 | $10,319,000 | +23.2% | 439,841 | +19.6% | 0.03% | +30.0% |
| Q3 2014 | $8,373,000 | +2.0% | 367,742 | +9.6% | 0.02% | -4.8% |
| Q2 2014 | $8,207,000 | -12.0% | 335,668 | -24.5% | 0.02% | -22.2% |
| Q1 2014 | $9,328,000 | +33.5% | 444,459 | +51.5% | 0.03% | +28.6% |
| Q4 2013 | $6,986,000 | +8.3% | 293,435 | -2.7% | 0.02% | -8.7% |
| Q3 2013 | $6,452,000 | +62.6% | 301,464 | +51.2% | 0.02% | +35.3% |
| Q2 2013 | $3,969,000 | – | 199,347 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hardman Johnston Global Advisors LLC | 6,178,402 | $170,833,000 | 11.32% |
| Tikvah Management LLC | 369,425 | $10,215,000 | 5.35% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 360,000 | $9,954,000 | 3.36% |
| Opus Point Partners Management, LLC | 160,000 | $4,424,000 | 2.92% |
| Exane Asset Management | 106,238 | $2,910,304,000 | 1.76% |
| Douglas C. Lane & Associates, Inc. | 1,918,338 | $53,042,000 | 1.44% |
| Granahan Investment Management | 1,051,000 | $29,060,000 | 1.00% |
| CRAMER ROSENTHAL MCGLYNN LLC | 2,285,569 | $63,196,000 | 0.95% |
| Sivik Global Healthcare LLC | 70,000 | $1,936,000 | 0.92% |
| PURA VIDA INVESTMENTS, LLC | 78,668 | $2,175,000 | 0.92% |